Tag: Type 2 Diabetes
Study: Dexcom G7 improves A1C in Type 2 diabetes
October 21, 2026HME News Staff
SAN DIEGO – Dexcom G7 users experienced an average 1.6% A1C reduction from a mean baseline of 8.8%, a 0.9% greater reduction compared with routine care, according to the results from the CONNECT randomized controlled trial published The New England Journal of Medicine. Dexcom G7 users also spent approximately five additional hours per day in the glucose target range of 70–180 mg/dL compared with those receiving routine care. “Publication of CONNECT in The New England Journal of...
Sequel’s twiist approved for adults with inulin-treated Type 2 diabetes
October 20, 2026HME News Staff
MANCHESTER, N.H. – The twiist Automated Insulin Delivery (AID) System has been cleared by the U.S. Food and Drug Administration (FDA) for use in adults over 18 with insulin-treated Type 2 diabetes. The clearance follows twiist's national launch for Type 1 diabetes in March 2026. "For many adults living with Type 2 diabetes, insulin therapy can feel like one more thing to manage in an already busy life," said Sequel CEO and Co-Founder Alan Lotvin, MD. "At Sequel, we believe...
Study: CGM use can improve diabetes management for Type 2 patients
October 15, 2026HME News Staff
AURORA, Colo. – Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with Type 2 diabetes who don't take insulin, according to findings from new research published in the New England Journal of Medicine.
The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below...
CGM could lower risk of dying for people with diabetes, according to new analysis
September 28, 2026HME News Staff
YARMOUTH, Maine – People with Type 2 diabetes on basal insulin who are starting continuous glucose monitoring (CGM) had a 44% lower risk of dying from any cause after one year compared with those who did not use CGM, according to an analysis of patient data being presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan Sept. 28-Oct. 2. The risk was 35% lower after two years, according to the analysis. Researchers say the analysis provides the first...
Study: Tandem’s AID can lower A1c in certain Type 2 diabetes patients
September 18, 2025HME News Staff
SAN DIEGO – Tandem Diabetes Care’s Control-IQ+ automated insulin delivery system can lower HbA1c’s in adults with insulin-treated Type 2 diabetes, according to a new study published in the American Diabetes Association’s Diabetes Care. The study, "Adults with Type 2 Diabetes Benefit from Automated Insulin Delivery Irrespective of C-peptide Level," is a sub-analysis from the 2IQP randomized, controlled trial. Of the 319 participants in the 2IQP trial, 254 were included...
Dexcom releases study, launches new CGM
May 22, 2024HME News Staff
LONDON – Nearly half of patients with Type 2 diabetes were unaware of the disease’s effects, according to a new study from Dexcom.
The “Dexcom State of Type 2 Report,” released in conjunction with the launch of the Dexcom ONE+ continuous glucose monitor, also found:
63% of people with diabetes are encountering difficulties in managing their disease, including challenges related to improving their diet or their mental health; and
42% of...
Groups collaborate to prevent diabetes
May 28, 2020HME News Staff
ALEXANDRIA, Va. - The National Community Pharmacists Association is partnering with the Association of Diabetes Care & Education Specialists and OmniSYS to prevent Type 2 diabetes. The initiative, funded by the Centers for Disease Control, will allow small independent pharmacies to offer the National Diabetes Prevention Program to people with pre-diabetes. “The National DPP will enable neighborhood pharmacies—the most accessible health care providers—to better identify those at...
Diabetes study: Current standard of care inadequate
November 28, 2018HME News Staff
SAN FRANCISCO -Sixty two percent of patients with Type 2 diabetes are not satisfied with their current standard of care, according to a new study from Virta Health.What's more, 66% of healthcare providers believe the average patient is unable to manage their disease with the current standard of care.The online study, conducted by students from Purdue University, sampled 168 adults and 48 healthcare providers in the United States.Other patient findings: 43% think information from their provider is...
No link between CPAP and glycemic control, study says
March 11, 2016HME News Staff
MELBOURNE, Australia - CPAP therapy may not improve glycemic control for people with Type 2 diabetes and obstructive sleep apnea after all, according to a new study in the American Journal of Respiratory and Critical Care Medicine.“Some uncontrolled studies have reported improved glucose control after starting CPAP, but some small controlled trials did not support this,” said lead study author Jonathan Shaw, head of population health at Melbourne's Baker IDI Heart and Diabetes Institute,...
Study: Disconnect on diabetes awareness
June 10, 2015HME News Staff
BETHESDA, Md. - More than half of the U.S. public doesn't know that diabetes can cause other major health issues, according to a new survey.Although 64% of Americans know someone with diabetes, 57% don't realize the disease can cause heart disease, kidney failure and blindness, among other issues, according to a study from Telcare, a digital health company.Furthermore, 63% of Americans don't know the difference between Type 2 and Type 1 diabetes, according to the survey.“The index clearly shows...